Effects of transcutaneous pulsed radiofrequency on patients with advanced cancer
收藏NIAID Data Ecosystem2026-03-10 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/21662
下载链接
链接失效反馈官方服务：
资源简介：
Interventions: PRF percutane radiofrequency
Primary outcome(s): Tumor markers
- Carcinoembryonic antigen (CEA) for colorectal cancer;
- Carcinoma antigen 15.3 (CA15.3) for breast cancer;
- Prostate-specific antigen(PSA) for prostate cancer:
- Carcinoma antigen 125 (CA125) for ovarian cancer.
Study Design: Non-randomized controlled trial, Open (masking not used), Uncontrolled, single, Other
创建时间：
2019-01-15
